OPKO Health, Inc. (TLV:OPK)
Israel · Delayed Price · Currency is ILS · Price in ILA 389.20
-2.30 (-0.59%)
At close: Jan 30, 2026
OPKO Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -180.4 | -53.22 | -188.86 | -328.41 | -30.14 | 30.59 |
Depreciation & Amortization | 93.29 | 98.18 | 105.3 | 108.66 | 78.72 | 85.36 |
Other Amortization | 5.74 | 1.97 | 1.22 | 1.16 | 0.79 | 0.85 |
Loss (Gain) From Sale of Assets | -159.33 | -184.89 | 1.32 | -19.01 | -33.92 | -10.68 |
Asset Writedown & Restructuring Costs | 1.01 | - | - | - | - | - |
Loss (Gain) From Sale of Investments | -18.36 | -114.43 | 17.65 | 153.84 | 3.97 | -0.1 |
Loss (Gain) on Equity Investments | 0.02 | 0.02 | 0.11 | 0.38 | 0.63 | 0.48 |
Stock-Based Compensation | 10.86 | 11.05 | 11.41 | 18.51 | 13.63 | 8.95 |
Other Operating Activities | 96.15 | 25.66 | 1.86 | -72.97 | 25.16 | 21.65 |
Change in Accounts Receivable | 7.6 | -0.22 | 3.41 | 128.6 | 5.23 | -150.44 |
Change in Inventory | -7.53 | 4.22 | 15.2 | 13.66 | 30.68 | -77.64 |
Change in Accounts Payable | -11.29 | -20.66 | 2.83 | -9.39 | -10.85 | 37.16 |
Change in Unearned Revenue | - | - | - | - | -15.91 | -5.39 |
Change in Other Net Operating Assets | -34.82 | 48.84 | 0.36 | -90.22 | -29.64 | 98.7 |
Operating Cash Flow | -197.03 | -183.49 | -28.2 | -95.19 | 38.34 | 39.48 |
Operating Cash Flow Growth | - | - | - | - | -2.89% | - |
Capital Expenditures | -15.03 | -25.01 | -16.28 | -24.58 | -32.16 | -33.68 |
Sale of Property, Plant & Equipment | 198.04 | 210.62 | 2.71 | 1.95 | 66.03 | 0.25 |
Cash Acquisitions | - | - | - | -1.76 | -4 | - |
Investment in Securities | 165.32 | 166.6 | -4.64 | 115.42 | 6.08 | 15.11 |
Investing Cash Flow | 348.33 | 352.21 | -18.2 | 91.04 | 35.95 | -18.33 |
Long-Term Debt Issued | - | 939.43 | 671.68 | 1,060 | 1,685 | 1,108 |
Long-Term Debt Repaid | - | -651.45 | -682.71 | -1,036 | -1,696 | -1,144 |
Net Debt Issued (Repaid) | -90.07 | 287.98 | -11.03 | 23.75 | -11.24 | -35.83 |
Issuance of Common Stock | - | - | - | - | 1.08 | 0.76 |
Repurchase of Common Stock | -50 | -90.22 | - | - | - | - |
Other Financing Activities | -0.12 | -13.59 | -0.27 | -0.77 | -0.19 | - |
Financing Cash Flow | -140.19 | 184.17 | -11.3 | 22.97 | -10.35 | -35.08 |
Foreign Exchange Rate Adjustments | -2.3 | -3.16 | 0.39 | -0.34 | -1.44 | 0.69 |
Net Cash Flow | 8.81 | 349.73 | -57.31 | 18.48 | 62.5 | -13.24 |
Free Cash Flow | -212.06 | -208.5 | -44.47 | -119.77 | 6.18 | 5.79 |
Free Cash Flow Growth | - | - | - | - | 6.68% | - |
Free Cash Flow Margin | -33.03% | -29.24% | -5.15% | -11.93% | 0.35% | 0.40% |
Free Cash Flow Per Share | -0.29 | -0.30 | -0.06 | -0.17 | 0.01 | 0.01 |
Cash Interest Paid | 38.11 | 20.88 | 8.14 | 7.42 | 8.52 | 10.91 |
Cash Income Tax Paid | 26.83 | 10.01 | 3.71 | 8.04 | 5.97 | -0.9 |
Levered Free Cash Flow | -129.74 | -129.55 | 16.65 | 250.37 | -235.06 | -16.45 |
Unlevered Free Cash Flow | -65.86 | -101.86 | 23.87 | 256.75 | -224.05 | -3.59 |
Change in Working Capital | -46.03 | 32.18 | 21.8 | 42.65 | -20.48 | -97.61 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.